Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study

被引:0
|
作者
Irini Chatziralli
Eleni Dimitriou
George Theodossiadis
Evgenia Bourouki
Eleni Bagli
George Kitsos
Panagiotis Theodossiadis
机构
[1] National and Kapodistrian University of Athens,2nd Department of Ophthalmology, Attikon Hospital
[2] University of Ioannina,Department of Ophthalmology
来源
International Ophthalmology | 2020年 / 40卷
关键词
Vitreous haemorrhage; Proliferative diabetic retinopathy; Ranibizumab; Vitrectomy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:841 / 847
页数:6
相关论文
共 50 条
  • [21] Prospective Comparison of Surgery Outcome Between Preoperative and Intraoperative Intravitreal Injection of Ranibizumab for Vitrectomy in Proliferative Diabetic Retinopathy Patients
    Li, Siying
    Tang, Jiyang
    Han, Xinyao
    Wang, Zongyi
    Zhang, Linqi
    Zhao, Mingwei
    Qu, Jinfeng
    OPHTHALMOLOGY AND THERAPY, 2022, 11 (05) : 1833 - 1845
  • [22] THE USE OF PERFLUORODECALIN IN PARS-PLANA VITRECTOMY FOR COMPLICATIONS OF PROLIFERATIVE DIABETIC-RETINOPATHY
    MATHIS, A
    PAGOT, V
    IDDER, A
    MALECAZE, F
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 1993, 16 (11): : 584 - 590
  • [23] Prospective Comparison of Surgery Outcome Between Preoperative and Intraoperative Intravitreal Injection of Ranibizumab for Vitrectomy in Proliferative Diabetic Retinopathy Patients
    Siying Li
    Jiyang Tang
    Xinyao Han
    Zongyi Wang
    Linqi Zhang
    Mingwei Zhao
    Jinfeng Qu
    Ophthalmology and Therapy, 2022, 11 : 1833 - 1845
  • [24] Intravitreal Ranibizumab for myopic choroidal neovascularization after pars plana vitrectomy and silicone oil tamponade
    Cascavilla, Maria Lucia
    Querques, Giuseppe
    Querques, Lea
    Codenotti, Marco
    Bandello, Francesco
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2013, 23 (06) : 913 - 916
  • [25] Is immediate treatment necessary for diabetic macular edema after pars plana vitrectomy for tractional complications of proliferative diabetic retinopathy?
    Umesh Chandra Behera
    Taraprasad Das
    Sobha Sivaprasad
    Padmaja Kumari Rani
    Rajiv Raman
    Manisha Agarwal
    Tushar Agarwal
    Suman Sahu
    Harshit Vaidya
    Bhavik Panchal
    International Ophthalmology, 2021, 41 : 3607 - 3614
  • [26] Is immediate treatment necessary for diabetic macular edema after pars plana vitrectomy for tractional complications of proliferative diabetic retinopathy?
    Behera, Umesh Chandra
    Das, Taraprasad
    Sivaprasad, Sobha
    Rani, Padmaja Kumari
    Raman, Rajiv
    Agarwal, Manisha
    Agarwal, Tushar
    Sahu, Suman
    Vaidya, Harshit
    Panchal, Bhavik
    INTERNATIONAL OPHTHALMOLOGY, 2021, 41 (11) : 3607 - 3614
  • [27] Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy
    Modarres, Mehdi
    Nazari, Hossein
    Falavarjani, Khalil Ghasemi
    Naseripour, Masood
    Hashemi, Masih
    Parvaresh, Mohammad Mehdi
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2009, 19 (05) : 848 - 852
  • [28] Same-Day Cancellation is Higher in Outpatient Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy
    Xi, Chunhua
    Zhang, Yi
    Yue, Jianying
    Liu, Ying
    Li, Ming
    Wang, Guyan
    RISK MANAGEMENT AND HEALTHCARE POLICY, 2022, 15 : 1965 - 1974
  • [29] Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab
    Gupta, Amod
    Bansal, Reema
    Gupta, Vishali
    Dogra, Mangat R.
    INTERNATIONAL OPHTHALMOLOGY, 2012, 32 (02) : 135 - 144
  • [30] Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab
    Amod Gupta
    Reema Bansal
    Vishali Gupta
    Mangat R. Dogra
    International Ophthalmology, 2012, 32 : 135 - 144